Suppr超能文献

从印度尼西亚人群中招募的S-美芬妥因4'-羟化代谢能力强和代谢能力差的个体中,氯胍的代谢情况。

Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.

作者信息

Setiabudy R, Kusaka M, Chiba K, Darmansjah I, Ishizaki T

机构信息

Department of Pharmacology, Faculty of Medicine, University of Indonesia, Jakarta.

出版信息

Br J Clin Pharmacol. 1995 Mar;39(3):297-303. doi: 10.1111/j.1365-2125.1995.tb04452.x.

Abstract
  1. The metabolism of proguanil (PG) was studied by measuring PG, cycloguanil (CG) and 4-chlorophenylbiguanide (CPB) in plasma and urine samples after an oral 200 mg dose of PG hydrochloride administered to 14 extensive (EMs) and 10 poor hydroxylators (PMs) of S-mephenytoin of Indonesian origin. 2. The mean ( +/- s.d.) values of the elimination half-life (t 1/2) and AUC of PG were significantly (P < 0.01) greater in the PM than in the EM group (20.6 +/- 3.1 vs 14.6 +/- 3.5 (95% confidence intervals of difference 3.1 to 8.9) h; and 5.43 +/- 1.89 vs 3.68 +/- 0.83 (0.58 to 2.91) micrograms ml-1 h). 3. Plasma concentrations of CG, an active metabolite, could not be detected in all PMs, and those of CPB were sufficiently high to determine a time-course in only four PMs. Mean AUC(0,24 h) values of CPB were significantly (P < 0.05) lower in the PM (n = 4) than in the EM group (n = 14) (0.47 +/- 0.13 vs 0.88 +/- 0.50 (-0.14 to 0.96) micrograms ml-1 h). 4. Log10 percentage urinary recovery of 4'-hydroxymephenytoin correlated significantly (P < 0.05) with the t 1/2 (rs = -0.661) and AUC (rs = -0.652) of PG. 5. PG, CG and CPB were detectable in urine at 12 h in all subjects. Log10 percentage urinary recovery of 4'-hydroxymephenytoin correlated significantly (P < 0.01) with urinary PG/CG (rs = -0.876), PG/CPB (rs = -0.833) and PG/(CG + CPB) (rs = -0.831) metabolic ratios.(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 对14名印度尼西亚裔S-美芬妥因代谢快(EMs)和10名代谢慢(PMs)的受试者口服200mg盐酸氯胍后,通过测量血浆和尿液样本中的氯胍(PG)、环氯胍(CG)和4-氯苯基双胍(CPB)来研究PG的代谢。2. PM组中PG的消除半衰期(t1/2)和AUC的均值(±标准差)显著高于EM组(P<0.01)(20.6±3.1对14.6±3.5(差异的95%置信区间为3.1至8.9)小时;5.43±1.89对3.68±0.83(0.58至2.91)μg/ml·h)。3. 在所有PM中均未检测到活性代谢物CG的血浆浓度,仅在4名PM中CPB浓度足够高以确定其时间进程。PM组(n = 4)中CPB的平均AUC(0,24 h)值显著低于EM组(n = 14)(P<0.05)(0.47±0.13对0.88±0.50(-0.14至0.96)μg/ml·h)。4. 4'-羟基美芬妥因的尿回收率对数百分比与PG的t1/2(rs = -0.661)和AUC(rs = -0.652)显著相关(P<0.05)。5. 所有受试者在12小时时尿液中均可检测到PG、CG和CPB。4'-羟基美芬妥因的尿回收率对数百分比与尿PG/CG(rs = -0.876)、PG/CPB(rs = -0.833)和PG/(CG + CPB)(rs = -0.831)代谢比显著相关(P<0.01)。(摘要截断于250字)

相似文献

4
Concordance between proguanil phenotype and CYP2C19 genotype in Chinese.
Eur J Clin Pharmacol. 2003 Nov;59(8-9):611-4. doi: 10.1007/s00228-003-0665-4. Epub 2003 Sep 12.
5
The multiple dose pharmacokinetics of proguanil.
Br J Clin Pharmacol. 1993 Jun;35(6):653-6. doi: 10.1111/j.1365-2125.1993.tb04197.x.
6
Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
Br J Clin Pharmacol. 1993 Aug;36(2):105-8. doi: 10.1111/j.1365-2125.1993.tb04204.x.
7
Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
Br J Clin Pharmacol. 1987 Dec;24(6):775-80. doi: 10.1111/j.1365-2125.1987.tb03245.x.
8
Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism.
Br J Clin Pharmacol. 1996 Mar;41(3):175-9. doi: 10.1111/j.1365-2125.1996.tb00179.x.
10
Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults.
Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):492-5. doi: 10.1016/0035-9203(90)90010-c.

引用本文的文献

1
Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome gene in six major ethnicities of Pakistan.
Bioengineered. 2021 Dec;12(1):4442-4451. doi: 10.1080/21655979.2021.1955809.
3
Concordance between proguanil phenotype and CYP2C19 genotype in Chinese.
Eur J Clin Pharmacol. 2003 Nov;59(8-9):611-4. doi: 10.1007/s00228-003-0665-4. Epub 2003 Sep 12.

本文引用的文献

1
A metabolite of paludrine with high antimalarial activity.
Nature. 1951 Dec 22;168(4288):1080. doi: 10.1038/1681080a0.
2
Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
Br J Clin Pharmacol. 1993 Aug;36(2):105-8. doi: 10.1111/j.1365-2125.1993.tb04204.x.
6
Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians.
Clin Pharmacol Ther. 1984 Nov;36(5):670-6. doi: 10.1038/clpt.1984.238.
9
Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
Br J Clin Pharmacol. 1987 Dec;24(6):775-80. doi: 10.1111/j.1365-2125.1987.tb03245.x.
10
Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
Chemotherapy. 1988;34(5):385-92. doi: 10.1159/000238597.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验